Expert consensus on interference factors and solutions for immunological testing

doi:10.3969/j.issn.1673-8640.2024.12.001

Abstract

Abstract:

Immunological testing is a qualitative or quantitative determination of analytes based on the binding of antigens and antibodies. In clinic，there are multiple interfering factors that can affect the results of immunological testing，mainly involving in the pre-，mid-，and post- analysis stages. Therefore，Beijing Medical Association Laboratory Medicine Branch and Shanghai Medical Association Laboratory Medicine Branch have formed an expert consensus on the interference factors and solutions for immunological testing，which can provide a reference for accurate determination of immunological projects.

Key words: Immunology, Testing, Interference factor, Control measure, Expert consensus

CLC Number:

R446.1

Beijing Medical Association Laboratory Medicine Branch, Shanghai Medical Association Laboratory Medicine Branch. Expert consensus on interference factors and solutions for immunological testing[J]. Laboratory Medicine, 2024, 39(12): 1131-1139.

References 67

[1]	YANG W, GUO Z, ZHOU Y, et al. Optimization of a screening method for macroprolactinemia[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2021,1175:122723.
[2]	HATTORI N, AISAKA K, YAMADA A. Prevalence and pathogenesis of macro-thyrotropin in neonates:analysis of umbilical cord blood from 939 neonates and their mothers[J]. Thyroid, 2023, 33(1):45-52.
[3]	LAFRENIÈRE M A, TANDON V, AINSWORTH C, et al. Storage conditions,sample integrity,interferences,and a decision tool for investigating unusual high-sensitivity cardiac troponin results[J]. Clin Biochem, 2023,115:67-76.
[4]	KAVSAK P A, AINSWORTH C, WORSTER A. An approach to investigating discordant high-sensitivity cardiac troponinⅠresults[J]. Can J Cardiol, 2021, 37(8):1292-1293.
[5]	KAVSAK P A, ROY C, MALINOWSKI P, et al. Macrocomplexes and discordant high-sensitivity cardiac troponin concentrations[J]. Ann Clin Biochem, 2018, 55(4):500-504. DOI PMID
[6]	WARNER J V, MARSHALL G A. High incidence of macrotroponinⅠwith a high-sensitivity troponinⅠassay[J]. Clin Chem Lab Med, 2016, 54(11):1821-1829.
[7]	LLAM L, ASPIN L, HERON R C, et al. Discrepancy between cardiac troponin assays due to endogenous antibodies[J]. Clin Chem, 2020, 66(3):445-454. DOI PMID
[8]	许慧. RF对TOURch-IgM抗体检测干扰观察[J]. 内蒙古中医药, 2012, 31(11):93-94.
[9]	谢良才, 刘天春, 范文, 等. 类风湿因子对免疫测定干扰的研究进展[J]. 医学综述, 2015(19):3495-3497.
[10]	谢良才, 范文, 徐磊, 等. RF对ELISA检测血清HBeAg假阴性干扰的分析[J]. 检验医学, 2017, 32(9):765-768. DOI
[11]	BARTELS E M, RIBEL-MADSEN S. Cytokine measurements and possible interference from heterophilic antibodies--problems and solutions experienced with rheumatoid factor[J]. Methods, 2013, 61(1):18-22. DOI PMID
[12]	ISMAIL A A. Identifying and reducing potentially wrong immunoassay results even when plausible and “not-unreasonable”[J]. Adv Clin Chem, 2014,66:241-294.
[13]	TTODD D J, KNOWLTON N, AMATO M, et al. Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor[J]. Arthritis Rheum, 2011, 63(4):894-903.
[14]	LEVIN O, MORRIS L F, WAH D T, et al. Falsely elevated plasma parathyroid hormone level mimicking tertiary hyperparathyroidism[J]. Endocr Pract, 2011, 17(2):e8-e11.
[15]	GULBAHAR O, KONCA DEGERTEKIN C, AKTURK M, et al. A case with immunoassay interferences in the measurement of multiple hormones[J]. J Clin Endocrinol Metab, 2015, 100(6):2147-2153. DOI PMID
[16]	BJERNER J, BØRMER O P, NUSTAD K. The war on heterophilic antibody interference[J]. Clin Chem, 2005, 51(1):9-11. PMID
[17]	ZANCHETTA M B, GIACOIA E, JERKOVICH F, et al. Asymptomatic elevated parathyroid hormone level due to immunoassay interference[J]. Osteoporos Int, 2021, 32(10):2111-2114.
[18]	CAVALIER E, CARLISI A, CHAPELLE J P, et al. False positive PTH results:an easy strategy to test and detect analytical interferences in routine practice[J]. Clin Chim Acta, 2008, 387(1-2):150-152.
[19]	TRELA M, PERERA S, SHEERAN T, et al. Citrullination facilitates cross-reactivity of rheumatoid factor with non-IgG1 Fc epitopes in rheumatoid arthritis[J]. Sci Rep, 2019, 9(1):12068. DOI PMID
[20]	BARTELS E M, FALBE WÄTJEN I, LITTRUP ANDERSEN E, et al. Rheumatoid factor and its interference with cytokine measurements:problems and solutions[J]. Arthritis, 2011,2011:741071.
[21]	KENNY P R, FINGER D R. Falsely elevated cardiac troponin-Ⅰin patients with seropositive rheumatoid arthritis[J]. J Rheumatol, 2005, 32(7):1258-1261.
[22]	DIMESKI G, CARTER A. Rare IgM interference with Roche/Hitachi modular glucose and γ-glutamyltransferase methods in heparin samples[J]. Clin Chem, 2005, 51(11):2202-2204.
[23]	SAVUKOSKI T, JACOBINO J, LAITINEN P, et al. Novel sensitive cardiac troponinⅠimmunoassay free from troponinⅠ-specific autoantibody interference[J]. Clin Chem Lab Med, 2014, 52(7):1041-1048.
[24]	ALGECIRAS-SCHIMNICH A. Thyroglobulin measurement in the management of patients with differentiated thyroid cancer[J]. Crit Rev Clin Lab Sci, 2018, 55(3):205-218.
[25]	王婷婷, 欧明慧, 曹丽娟. 热灭活补体活性的血清对间充质干细胞和免疫细胞培养的优化效应[J]. 中国细胞生物学学报, 2022, 44(11):2118-2126.
[26]	ANANI W Q, ZEEVI A, LUNZ J G. EDTA treatment of serum unmasks complement-mediated prozone inhibition in human leukocyte antigen antibody testing[J]. Am J Clin Pathol, 2016, 146(3):346-352. DOI PMID
[27]	RAMACHANDRAN S, HACKETT G I, STRANGE R C, et al. Sex hormone binding globulin:a review of its interactions with testosterone and age,and its impact on mortality in men with type 2 diabetes[J]. Sex Med Rev, 2019, 7(4):669-678.
[28]	BAGGA A D, JOHNSON B P, ZHANG Q. A minimal human physiologically based kinetic model of thyroid hormones and chemical disruption of plasma thyroid hormone binding proteins[J]. Front Endocrinol(Lausanne), 2023,14:1168663.
[29]	SHEIKH I A, BEG M A. Structural binding interactions of tetrabromobisphenol a with sex steroid nuclear receptors and sex hormone-binding globulin[J]. J Appl Toxicol, 2020, 40(6):832-842. DOI PMID
[30]	汪国庆, 赵军, 周玉球. 脂血标本对时间分辨荧光免疫分析法测定游离雌三醇水平的影响[J]. 国际检验医学杂志, 2017, 38(2):189-190.
[31]	朱文静. 高脂血标本对临床检验项目的干扰及消除方法[J]. 智慧健康, 2022, 8(3):37-39.
[32]	HUNSAKER J J H, LA'ULU S L, WYNESS S P, et al. Lipemic interference of ceruloplasmin assays-an evaluation of lipid removal methods[J]. Clin Chim Acta, 2018,480:71-78.
[33]	SOH S X, LOH T P, SETHI S K, et al. Methods to reduce lipemic interference in clinical chemistry tests:a systematic review and recommendations[J]. Clin Chem Lab Med, 2021, 60(2):152-161.
[34]	GOSSELIN R C. Ultracentrifugation for coagulation testing[J]. Methods Mol Biol, 2023,2663:63-70.
[35]	CARUSO B, BOVO C, GUIDI G C. Causes of preanalytical interferences on laboratory immunoassays-a critical review[J]. EJIFCC, 2020, 31(1):70-84.
[36]	刘蕊, 李刚, 崔小璠. 胆红素和血红蛋白对不同尿白蛋白检测方法结果干扰的研究[J]. 检验医学, 2012, 27(7):564-567.
[37]	陈洋利. 血清稀释法消除黄疸血标本对部分生化项目干扰的临床研究[D]. 衡阳: 南华大学, 2020.
[38]	YUKSEL M, LUO W, MCCLOY B, et al. A precise and rapid early pregnancy test:development of a novel and fully automated electrochemical point-of-care biosensor for human urine samples[J]. Talanta, 2023,254:124156.
[39]	LEE C L, CHIU P C, HAUTALA L, et al. Human chorionic gonadotropin and its free β-subunit stimulate trophoblast invasion independent of LH/hCG receptor[J]. Mol Cell Endocrinol, 2013, 375(1-2):43-52.
[40]	韩建华, 程歆琦, 吴洁, 等. M蛋白对免疫透射比浊法和免疫散射比浊法检测免疫球蛋白的干扰[J]. 检验医学, 2019, 34(3):197-201. DOI
[41]	杨浩, 吕勤珍, 许军生, 等. 免疫学检验分析前血液标本采集质量控制的临床意义[J]. 临床医学, 2018, 38(4):82-84.
[42]	HASLAM S, OAKEY J, BROWN A, et al. A comparison of biotin interference in routine immunoassays on the Roche Cobas 8000,Beckman Coulter DXi and Siemens Advia Centaur XPT immunoassay platforms[J]. Clin Chem Lab Med, 2019, 57(11):e287-e290.
[43]	YLLI D, SOLDIN S J, STOLZE B, et al. Biotin interference in assays for thyroid hormones,thyrotropin and thyroglobulin[J]. Thyroid, 2021, 31(8):1160-1170.
[44]	倪佳佳, 龙钰, 张丽, 等. 生物素、异嗜性抗体、甲状腺激素自身抗体干扰甲状腺功能检测1例报道[J]. 检验医学, 2023, 38(6):599-602. DOI
[45]	WILLEMAN T, CASEZ O, FAURE P, et al. Evaluation of biotin interference on immunoassays:new data for troponinⅠ,digoxin,NT-Pro-BNP,and progesterone[J]. Clin Chem Lab Med, 2017, 55(10):e226-e229.
[46]	王晓燕, 李玉杰, 武双全, 等. 生物素导致电化学发光法检测高敏肌钙蛋白T假阴性1例[J]. 中国现代医药杂志, 2023, 25(6):76-79.
[47]	JAMES A, STALAN J, KUZHIVELY J. Biotin induced biochemical hyperthyroidism:a case report and review of the literature[J]. J Med Case Rep, 2023, 17(1):266.
[48]	DASGUPTA A, YEO K J. Biotin interference in immunoassays and patient safety[J]. Am J Clin Pathol, 2023, 159(1):1-2.
[49]	刘栋, 仝慧, 陈斌, 等. 外源性生物素对基于生物素-链霉亲和素化学发光技术干扰的研究进展[J]. 现代检验医学杂志, 2021, 36(3):161-164.
[50]	LI J, WAGAR E A, MENG Q H. Comprehensive assessment of biotin interference in immunoassays[J]. Clin Chim Acta, 2018,487:293-298.
[51]	WAUTHIER L, PLEBANI M, FAVRESSE J. Interferences in immunoassays:review and practical algorithm[J]. Clin Chem Lab Med, 2022, 60(6):808-820.
[52]	NATRAJAN A, SHARPE D, COSTELLO J, et al. Enhanced immunoassay sensitivity using chemiluminescent acridinium esters with increased light output[J]. Anal Biochem, 2010, 406(2):204-213. DOI PMID
[53]	NAKAZONO M, NANBU S, AKITA T, et al. Acridinium ester chemiluminescence:methyl substitution on the acridine moiety[J]. J Oleo Sci, 2021, 70(11):1677-1684.
[54]	PIEKOS M, ZADYKOWICZ B. What other than acridinium esters? Computational search for new acridinium-based chemiluminogens[J]. Int J Mol Sci, 2023, 24(11):9468.
[55]	FAVRESSE J, BURLACU M C, MAITER D, et al. Interferences with thyroid function immunoassays:clinical implications and detection algorithm[J]. Endocr Rev, 2018, 39(5):830-850.
[56]	YANAGISAWA Y, ISOBE K, NAITO A, et al. Influence of in vitro hemolysis on 80 different laboratory tests[J]. Clin Lab, 2017, 63(2):219-226.
[57]	胡孝彬, 张梦玲, 曾静, 等. 溶血对电化学发光法检测心脏标志物的影响[J]. 实用医技杂志, 2015(2):171-172.
[58]	SODI R, DARN S M, DAVISON A S, et al. Mechanism of interference by haemolysis in the cardiac troponin T immunoassay[J]. Ann Clin Biochem, 2006, 43(1):49-56.
[59]	张玉静. 不同程度的溶血和脂血标本对ELISA法检测HBsAg结果的影响观察[J]. 当代医学, 2020, 26(5):136-137.
[60]	马伟刚. 溶血标本在应用化学发光免疫分析法检测HIV抗体时对检测结果的影响[J]. 临床研究, 2022, 30(9):125-128.
[61]	潘永康. 溶血对电化学发光微粒子免疫法检测胰岛素与C肽结果的影响[J]. 医学食疗与健康, 2022, 20(3):157-159.
[62]	QIN X, ZHENG C, LI Y, et al. Evaluation of the effect of hemolysis on quantitative chemiluminescent immunoassay results for 10 analytes[J]. Clin Lab, 2021, 67(11):210150.
[63]	KANIAS T, STONE M, PAGE G P, et al. Frequent blood donations alter susceptibility of red blood cells to storage- and stress-induced hemolysis[J]. Transfusion, 2019, 59(1):67-78. DOI PMID
[64]	HEIREMAN L, VAN GEEL P, MUSGER L, et al. Causes,consequences and management of sample hemolysis in the clinical laboratory[J]. Clin Biochem, 2017, 50(18):1317-1322.
[65]	罗宏伟. 标本溶血对生化检验结果的影响[J]. 中国实用医药, 2020, 15(32):205-206.
[66]	TOKUMARU M, OHBA K, KASHIWABARA Y, et al. Falsely elevated thyroid hormone levels associated with fibrin interference in patients receiving oral anticoagulant therapy[J]. Ann Clin Biochem, 2023, 60(4):249-258.
[67]	AKAGAC A E, YAVUZ H B. Fibrin clot interference in a human chorionic gonadotrophin assay causing a false Down syndrome screening result[J]. Biochem Med(Zagreb), 2023, 33(1):011001.